AKT1 and colorectal cancer: However, another study suggests that PUS7 also can activate the Wnt/β-catenin pathway by acting on Sirtuin 1 [29] and PI3K/AKT/mTOR signaling pathway [30], indicating that PUS7 may simultaneously act on multiple downstream targets and promote colorectal cancer progression.